Beam angle evaluation to improve inter-fraction motion robustness in pelvic lymph node irradiation with proton therapy

References

• Langendijk JA, Lambin P, De Ruysscher D, et al. Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach. Radiother Oncol. 2013;107:267–273.
   PubMed Web of Science ®Google Scholar
• Widesott L, Pierelli A, Fiorino C, et al. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis. Int J Radiat Oncol Biol Phys. 2011;80:1589–1600.
   PubMed Web of Science ®Google Scholar
• Muren LP, Rossi C, Hug E, et al. Establishing and expanding the indications for proton and particle therapy. Acta Oncol. 2013;52:459–462.
   PubMed Web of Science ®Google Scholar
• Engelsman M, Schwarz M, Dong L. Physics controversies in proton therapy. Semin Radiat Oncol. 2013;23:88–96.
   PubMed Web of Science ®Google Scholar
• Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol. 1999;44:185–205.
   PubMed Web of Science ®Google Scholar
• Chen W, Unkelbach J, Trofimov A, et al. Including robustness in multi-criteria optimization for intensity-modulated proton therapy. Phys Med Biol. 2013;57:591–608.
   Web of Science ®Google Scholar
• Park PC, Cheung JP, Zhu XR, et al. Statistical assessment of proton treatment plans under setup and range uncertainties. Int J Radiat Oncol Biol Phys. 2013;86:1007–1013.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Chan TCY, Bortfeld T. Accounting for range uncertainties in the optimization of intensity modulated proton therapy. Phys Med Biol. 2007;52:2755–2773.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Bortfeld T, Martin BC, et al. Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning. Med Phys. 2009;36:149–163.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Muren LP, Bentzen L, et al. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncol. 2013;52:521–527.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Bentzen L, Petersen JBB, et al. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques. Acta Oncol. 2011;50:926–934.
   PubMed Web of Science ®Google Scholar
• Liu W, Frank SJ, Li X, et al. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization. Med Phys. 2013;40:21709.
   Web of Science ®Google Scholar
• Casares-Magaz O, Toftegaard J, Muren LP, et al. A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer. Acta Oncol. 2014;53:1058–1063.
   PubMed Web of Science ®Google Scholar
• Andersen AG, Casares-Magaz O, Muren LP, et al. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation. Acta Oncol. 2015;54:1643–1650.
   PubMed Web of Science ®Google Scholar
• Mori S, Lu H-M, Wolfgang J. a, et al. Effects of interfractional anatomical changes on water-equivalent pathlength in charged-particle radiotherapy of lung cancer. JRR. 2009;50:513–519.
   PubMed Web of Science ®Google Scholar
• Liao L, Lim GJ, Li Y, et al. Robust optimization for intensity modulated proton therapy plans with multi-isocenter large fields. Int J Part Ther. 2016;IJPT-16-00012.1.
   Google Scholar
• Li Y, Niemela P, Liao L, et al. Selective robust optimization: a new intensity-modulated proton therapy optimization strategy. Med Phys. 2015;42:4840–4847.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhang X, Li Y, et al. Robust optimization of intensity modulated proton therapy. Med Phys. 2012;39:1079–1091.
   PubMed Web of Science ®Google Scholar
• van der Voort S, van de Water S, Perkó Z, et al. Robustness recipes for minimax robust optimization in intensity modulated proton therapy for oropharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2016;95:163–170.
   PubMed Web of Science ®Google Scholar
• Chang JY, Li H, Zhu XR, et al. Clinical implementation of intensity modulated proton therapy for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2014;90:809–818.
   PubMed Web of Science ®Google Scholar
• Mori S, Wolfgang J, Lu H-M, et al. Quantitative assessment of range fluctuations in charged particle lung irradiation. Int J Radiat Oncol Biol Phys. 2008;70:253–261.
   PubMed Web of Science ®Google Scholar
• Matney JE, Park PC, Li H, et al. Perturbation of water-equivalent thickness as a surrogate for respiratory motion in proton therapy. J Appl Clin Med Phys. 2016;17:5795.
   PubMed Web of Science ®Google Scholar
• Muren LP, Wasbø E, Helle SI, et al. Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences. Int J Radiat Oncol Biol Phys. 2008;71:1034–1041.
   PubMed Web of Science ®Google Scholar
• Krämer M, Jäkel O, Haberer T, et al. Treatment planning for scanned ion beams. Radiother Oncol. 2004;73(Suppl 2):S80–S85.
   PubMed Web of Science ®Google Scholar
• Toftegaard J, Petersen JBB, Bassler N. PyTRiP – a toolbox and GUI for the proton/ion therapy planning system TRiP. J Phys: Conf Ser. 2014;489:12045.
   Google Scholar
• Chaikh A, Giraud J-Y, Perrin E, et al. The choice of statistical methods for comparisons of dosimetric data in radiotherapy. Radiat Oncol. 2014;9:205.
   PubMed Web of Science ®Google Scholar
• Bernatowicz K, Lomax AJ, Knopf A. Comparative study of layered and volumetric rescanning for different scanning speeds of proton beam in liver patients. Phys Med Biol. 2013;58:7905–7920.
   PubMed Web of Science ®Google Scholar
• Bernatowicz K, Zhang Y, Weber D, et al. 4D optimized treatment planning for actively scanned proton therapy delivered to moving target volume. Med Phys. 2015;42:3615.
   Web of Science ®Google Scholar
• Michalski JM, Gay H, Jackson A, et al. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys. 2010;76:S123–S129.
   PubMed Web of Science ®Google Scholar
• Cheung MR, Tucker SL, Dong L, et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007;67:1059–1065.
   PubMed Web of Science ®Google Scholar
• Fredriksson A, Forsgren A, Hårdemark B. Minimax optimization for handling range and setup uncertainties in proton therapy. Med Phys. 2011;38:1672–1684.
   PubMed Web of Science ®Google Scholar
• Standard New Feature/Enhancement Description Eclipse^TM Treatment Planning System for Proton Therapy v13.7 Key Features n.d.
   Google Scholar
• Park Y-K, Sharp GC, Phillips J, et al. Proton dose calculation on scatter-corrected CBCT image: feasibility study for adaptive proton therapy. Med Phys. 2015;42:4449–4459.
   PubMed Web of Science ®Google Scholar
• Veiga C, Janssens G, Teng C-L, et al. First clinical investigation of CBCT and deformable registration for adaptive proton therapy of lung cancer. Int J Radiat Oncol Biol Phys. 2016;95:549–559.
   PubMed Web of Science ®Google Scholar
• Thing RS, Bernchou U, Mainegra-Hing E, et al. Hounsfield unit recovery in clinical cone beam CT images of the thorax acquired for image guided radiation therapy. Phys Med Biol. 2016;61:5781–5802.
   PubMed Web of Science ®Google Scholar
• Kurz C, Dedes G, Resch A, et al. Comparing cone-beam CT intensity correction methods for dose recalculation in adaptive intensity-modulated photon and proton therapy for head and neck cancer. Acta Oncol. 2015;54:1651–1657.
   PubMed Web of Science ®Google Scholar
• Unkelbach J, Botas P, Giantsoudi D, et al. Reoptimization of intensity modulated proton therapy plans based on linear energy transfer. Int J Radiat Oncol Biol Phys. 2016;96:1097–1106.
   PubMed Web of Science ®Google Scholar
• Cao W, Lim GJ, Li Y, et al. Improved beam angle arrangement in intensity modulated proton therapy treatment planning for localized prostate cancer. Cancers (Basel). 2015;7:574–584.
   PubMed Web of Science ®Google Scholar